Biologics Contract Manufacturing Organization (CMO) and developer of biosimilars. Products include: TuNEX®(etanercept), LusiNEX (tocilizumab), AiNEX (bevacizumab), GranNEX (G-CSF), Omalizumab, Adalimumab, Trastuzumab.
Hsinchu 30077, Taiwan
Founded as a collaboration between Taiwan’s Industrial Technology Research Institute (ITRI) and several private companies and research institutes. Manufacturers of whole genome human, mouse and miRNA microarrays, and providers of gene expression profiling and analysis consultation services. Key products are the ‘OneArray’ DNA microarrays.
Pharmaceutical technology and regulatory services, OEM/ODM manufacturer, CMO provider, and API manufacturer.
Has four plants:
Synthetic API plant
Sterile injection plant
Sterile synthetic API plant for oncology products
Sterile injection plant for oncology products
Services / technologies include:
Drug carriers, intermediates, API synthesis
Sterile API manufacturing
Aseptic filling manufacturing (powder, liquid and lyophilized powder)
Oral solid dosage drug development (Granules, tablets, capsules, sustained-release dosages, etc.)
Hsinchu County 30261, Taiwan
Developing platforms to enable faster clinical sample data acquisition and analysis, using PanelStation and PanelChip equipment to simplify the qPCR preparation procedures.
Cord blood and adult stem cell banking services.
The development of novel cellular therapeutics for the treatment of diseases with unmet or under-served medical needs. Offers proprietary isolation, purification, and amplification of standardized stem cell products for research and clinical development in multiple indications.
In December 2015, Steminent received US FDA Orphan Drug Designation for Stemchymal in the treatment of PolyQ SCAs.